4100 Seraing
Contipharma is a Belgian company that develops and markets customized medical solutions providing concrete answers to unresolved public health issues. The company specializes in the development of tailor-made, accessible medical solutions for therapeutic purposes (notably through the provision of generic and biosimilar medicines), diagnostic purposes and healthcare optimization purposes. Contipharma is currently developing two flagship projects for the African continent. The first project involves the supply of drugs via modular units for the local production of drugs complying with European regulations. The second involves the development of non-invasive diagnostic tests for various pathologies. In addition to these two main projects, the company is establishing privileged partnerships with key players, notably local technical and political decision-makers, as well as with international technical and financial organizations, to meet the specific needs of this complex market with its growing demand for high quality standards.
